Peripheral Artery Disease affects over 8.5 million Americans and is a major predictor of cardiovascular events. VitalScan ANS+ performs non-invasive vascular studies including arterial Doppler and ankle-brachial index — identifying PAD in at-risk patients during a routine 15-minute visit.

PAD affects over 8.5 million Americans over age 40, yet it is significantly underdiagnosed. Patients with PAD have a 3–6x increased risk of cardiovascular mortality. Non-invasive vascular testing — including ankle-brachial index (ABI), arterial Doppler, and pulse wave velocity — enables early detection and risk stratification. VitalScan ANS+ brings these studies into the primary care, cardiology, and podiatry office in a single 15-minute assessment.
93922–93971Vascular studies including arterial Doppler and ABI95921–95924Autonomic nervous system function testingEstimated monthly revenue
3 tests/day × ~$190 avg = $11,400/month
Based on 3 tests per day, 20 working days per month. Actual reimbursement varies by payer and region.
Non-invasive, automated, and reproducible. The entire assessment fits into a single patient visit — no special prep, no dedicated technician required.
Get a personalized ROI analysis with clinical workflow, CPT billing guidance, and financing options — including Section 179 and grant pathways.